{
    "code": "02024878",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024878",
    "time": "2016-05-27 05:17:14",
    "許可證字號": "衛署藥輸字第024878號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/09\/03",
    "發證日期": "97\/09\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202487803",
    "中文品名": "泰嘉錠 250 毫克膜衣錠",
    "英文品名": "Tykerb tablets 250mg",
    "適應症": "在和capecitabine併用的情況下，TYKERB適用於治療腫瘤有HER2 (ErbB2)過度表現之現象且曾接受anthracycline、taxane以及trastuzumab治療後病況惡化之後期或轉移性乳癌患者。在和芳香&#37238;抑制劑(aromatase inhibitor)併用的情況下，TYKERB適用於治療Her2\/neu (ErbB2)過度表現，荷爾蒙接受體呈陽性之轉移性乳癌患者，但未曾接受過trastuzumab或芳香&#37238;抑制劑治療，且目前不打算進行化療之停經後婦女。",
    "劑型": "116膜衣錠",
    "包裝": "1000錠以下瓶裝 1000錠以下盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "LAPATINIB DITOSYLATE MONOHYDRATE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中正區仁愛路二段99號11、12、13樓",
    "主製造廠": {
        "製造廠名稱": "F130044400  GLAXO OPERATIONS UK LTD.",
        "製造廠廠址": "PRIORY STREET, WARE, HERTFORDSHIRE SG12 0DJ, UNITED KINGDOM",
        "製造廠公司地址": "",
        "製造廠國別": "UNITED KINGDOM",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F410122000  GLAXO WELLCOME, S.A.",
            "製造廠廠址": "AVENIDA EXTREMADURA 3, 09400 ARANDA de DUERO, BURGOS, SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": "分包裝廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013002020",
            "成分名稱": "LAPATINIB DITOSYLATE MONOHYDRATE",
            "含量描述": "Equivalent to 250mg Lapatinib free base",
            "含量": "405.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020248780001-104-12-22.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024878&Seq=001&Type=9"
        },
        {
            "title": "020248780003-104-07-07.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024878&Seq=006&Type=8"
        },
        {
            "title": "020248780002-104-07-07.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024878&Seq=005&Type=8"
        },
        {
            "title": "020248780009___20120827.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024878&Seq=004&Type=8"
        },
        {
            "title": "020248780008___20120827.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024878&Seq=003&Type=8"
        },
        {
            "title": "020248780006___20120827.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024878&Seq=002&Type=8"
        },
        {
            "title": "020248780005___20120827.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024878&Seq=001&Type=8"
        }
    ]
}